Proteomics Market By Component (Reagents, Instruments, Services), By Application (Drug Discovery, Disease Diagnosis, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035

Proteomics Market By Component (Reagents, Instruments, Services), By Application (Drug Discovery, Disease Diagnosis, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035

The global proteomics market was valued at $32.8 billion in 2023 and is projected to reach $161.9 billion by 2035, growing at a CAGR of 14.2% from 2024 to 2035. Proteomics is a branch of molecular biology that focuses on the study of proteins, their structures, functions, and interactions within a biological system. Unlike genomics, which deals with the study of an organism's entire genome, proteomics specifically targets the proteome, which refers to the complete set of proteins expressed by a cell, tissue, or organism. The field of proteomics encompasses various techniques and methodologies aimed at understanding the roles and behaviors of proteins in biological processes, including protein expression profiling, protein-protein interactions, post-translational modifications, and protein localization.
The proteomics market growth is attributed to high adoption of proteomics in disease diagnosis, technological advancements, and increase in research in life sciences. Proteomics, the large-scale study of proteins, offers a comprehensive understanding of the dynamic interplay between proteins within biological systems, shedding light on disease pathogenesis and progression. According to a 2021 article by National Library of Medicine, it was reported that cancer proteomics unraveled key information in mechanistic studies on tumor growth and metastasis, which has contributed to the identification of clinically applicable biomarkers as well as therapeutic targets. With advancements in technology, such as mass spectrometry and protein microarray techniques, proteomics enables researchers and clinicians to identify biomarkers indicative of specific diseases with unprecedented accuracy and sensitivity. Thus, the increasing adoption of proteomics in disease diagnosis is expected to drive growth of proteomics industry.The proteomics market is experiencing a significant surge, largely driven by the increasing emphasis on research in the life sciences sector. As scientific understanding deepens and technological advancements accelerate, the demand for proteomics solutions has grown exponentially. Proteomics, the study of proteins and their functions within biological systems, plays a pivotal role in elucidating complex cellular mechanisms, disease pathways, and drug interactions. With life sciences research expanding across various disciplines such as genomics, transcriptomics, and metabolomics, proteomics has emerged as a complementary tool offering crucial insights into the intricate workings of biological systems. For instance, according to 2021 report by National Library of Medicine, it was reported that proteomics has become an important field in molecular sciences, as it provides valuable information on the identity, expression levels, and modification of proteins. Moreover, the rise of personalized medicine and the quest for targeted therapies have fueled the need for precise protein analysis techniques. This has propelled investments in proteomics technologies, including mass spectrometry, protein microarrays, and bioinformatics solutions, to develop more accurate diagnostic tools and therapeutic interventions. Thus, the rise in research in the life sciences sector is expected to drive the growth of the market.The proteomics market is segmented on the basis of component, application, and region. By component, the market is divided into reagents, instruments and services. By application, the market is divided into drug discovery, diseases diagnosis, and other. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).Major key players that operate in the proteomics market are Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Danaher Corporation, Bruker Corporation, Waters Corporation, Perkin Elmer Inc, Horiba Ltd., Merck KGaA, Agilent Technologies Inc., Li-Cor Inc. Key players have adopted collaboration, and product launch as a key developmental strategy to improve the product portfolio of the proteomics market.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the proteomics market analysis from 2023 to 2035 to identify the prevailing proteomics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the proteomics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global proteomics market trends, key players, market segments, application areas, and market growth strategies.
Regulatory Guidelines
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Component

Reagents
Reagents Type
Microarray
X Ray Crystallography
Spectrometry
Chromatography
Electrophoresis
Immunoassay
Protein Fractionation Reagents
Instruments
Instruments Type
Microarray
Spectrometry
Chromatography
Electrophoresis
Surface Plasmon Resonace
X Ray Crystallography
Protein Fractionation Reagents
Services

By Application

Drug Discovery
Disease Diagnosis
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Thermo Fisher Scientific Inc.
Merck KGaA
Waters Corporation
Bio-Rad Laboratories Inc
Agilent Technologies Inc.
Li-Cor Inc
Bruker Corporation○ Perkin Elmer Inc
Danaher Corporation○ Horiba Ltd.